{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:22:02Z","timestamp":1781742122773,"version":"3.54.5"},"reference-count":10,"publisher":"Cambridge University Press (CUP)","issue":"12","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infect. Control Hosp. Epidemiol."],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Using samples collected for VRE surveillance, we evaluated unit admission prevalence of carbapenem-resistant <jats:italic>Enterobacteriaceae<\/jats:italic> (CRE) perirectal colonization and whether CRE carriers (unknown to staff) were on contact precautions for other indications. CRE colonization at unit admission was infrequent (3.9%). Most CRE carriers were not on contact precautions, representing a reservoir for healthcare-associated CRE transmission.<\/jats:p>","DOI":"10.1017\/ice.2018.236","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T03:02:46Z","timestamp":1538362966000},"page":"1491-1493","source":"Crossref","is-referenced-by-count":13,"title":["How frequently are hospitalized patients colonized with carbapenem-resistant <i>Enterobacteriaceae<\/i> (CRE) already on contact precautions for other indications?"],"prefix":"10.1017","volume":"39","author":[{"given":"Katherine E.","family":"Goodman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J.","family":"Simner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eili Y.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abida Q.","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Gadala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Rock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranita D.","family":"Tamma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Cosgrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa L.","family":"Maragakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Milstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the CDC Prevention Epicenters Program","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the CDC MIND-Healthcare Program","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2018,10,1]]},"reference":[{"key":"S0899823X18002362_ref2","unstructured":"Facility Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE)\u2014 November 2015 Update CRE Toolkit. Centers for Disease Control and Prevention website. https:\/\/www.cdc.gov\/hai\/organisms\/cre\/cre-toolkit\/index.html. Published 2015. Accessed September 5, 2018."},{"key":"S0899823X18002362_ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy094"},{"key":"S0899823X18002362_ref6","first-page":"2006","article-title":"Vital signs: containment of novel multidrug-resistant organisms and resistance mechanisms\u2014United States","volume":"67","author":"Woodworth","year":"2018","journal-title":"Morb Mortal Wkly Rep"},{"key":"S0899823X18002362_ref7","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw282"},{"key":"S0899823X18002362_ref1","unstructured":"Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention website. https:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/index.html. Published 2013. Accessed September 5, 2018."},{"key":"S0899823X18002362_ref8","doi-asserted-by":"publisher","DOI":"10.1086\/673157"},{"key":"S0899823X18002362_ref4","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2018"},{"key":"S0899823X18002362_ref3","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00548-16"},{"key":"S0899823X18002362_ref5","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00193-17"},{"key":"S0899823X18002362_ref10","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.2016.1106940"}],"container-title":["Infection Control &amp; Hospital Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0899823X18002362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T18:38:28Z","timestamp":1555094308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0899823X18002362\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0899823X18002362"],"URL":"https:\/\/doi.org\/10.1017\/ice.2018.236","relation":{},"ISSN":["0899-823X","1559-6834"],"issn-type":[{"value":"0899-823X","type":"print"},{"value":"1559-6834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,1]]}}}